Lahore: Citi Pharma Limited convened an Extra Ordinary General Meeting at its head office in Lahore on June 26, 2025. Shareholders participated both in person and via video link to deliberate on the resolutions presented.

The key item on the agenda was the confirmation and adoption of the minutes from the previous Annual General Meeting held on October 28, 2025. After thorough consideration, the shareholders adopted the resolution with unanimous consent.

According to information available from the Pakistan Stock Exchange (PSX), the resolutions were certified as part of the regulatory compliance process, aligning with the PSX regulations clause 5.6.9(b).

This meeting is categorized under the designated market category of the Pakistan Stock Exchange.